Kiseleva I, Larionova N, Fedorova E, Bazhenova E, Dubrovina I, Isakova-Sivak I
Open Microbiol J. 2014; 8:59-70.
PMID: 25132869
PMC: 4133923.
DOI: 10.2174/1874285801408010059.
Shcherbik S, Pearce N, Levine M, Klimov A, Villanueva J, Bousse T
PLoS One. 2014; 9(3):e92580.
PMID: 24647786
PMC: 3960276.
DOI: 10.1371/journal.pone.0092580.
Tannock G, Romanova J, Paul J
Arch Virol. 1995; 140(1):201-9.
PMID: 7646346
DOI: 10.1007/BF01309736.
Murphy B, Maassab H, Wood Jr F, Chanock R
Infect Immun. 1981; 32(2):960-3.
PMID: 7251154
PMC: 351536.
DOI: 10.1128/iai.32.2.960-963.1981.
Murphy B, Chanock R, Clements M, ANTHONY W, Sear A, Cisneros L
Infect Immun. 1981; 32(2):693-7.
PMID: 7251144
PMC: 351503.
DOI: 10.1128/iai.32.2.693-697.1981.
Evaluation of influenza A/Hong Kong/123/77 (H1N1) ts-1A2 and cold-adapted recombinant viruses in seronegative adult volunteers.
Murphy B, Rennels M, DOUGLAS Jr R, Betts R, Couch R, Cate Jr T
Infect Immun. 1980; 29(2):348-55.
PMID: 7216417
PMC: 551124.
DOI: 10.1128/iai.29.2.348-355.1980.
Live influenza A/Victoria/75 (H3N2) virus vaccines: reactogenicity, immunogenicity, and protection against wild-type virus challenge.
CATE T, Couch R
Infect Immun. 1982; 38(1):141-6.
PMID: 7141686
PMC: 347709.
DOI: 10.1128/iai.38.1.141-146.1982.
Secretory and systemic immunological response in children infected with live attenuated influenza A virus vaccines.
Murphy B, Nelson D, Wright P, Tierney E, Phelan M, Chanock R
Infect Immun. 1982; 36(3):1102-8.
PMID: 7095844
PMC: 551444.
DOI: 10.1128/iai.36.3.1102-1108.1982.
Dose response of A/Alaska/6/77 (H3N2) cold-adapted reassortant vaccine virus in adult volunteers: role of local antibody in resistance to infection with vaccine virus.
Clements M, ODonnell S, Levine M, Chanock R, Murphy B
Infect Immun. 1983; 40(3):1044-51.
PMID: 6852910
PMC: 348156.
DOI: 10.1128/iai.40.3.1044-1051.1983.
Relative immunogenicity of the cold-adapted influenza virus A/Ann Arbor/6/60 (A/AA/6/60-ca), recombinants of A/AA/6/60-ca, and parental strains with similar surface antigens.
Tannock G, Paul J, BARRY R
Infect Immun. 1984; 43(2):457-62.
PMID: 6693167
PMC: 264316.
DOI: 10.1128/iai.43.2.457-462.1984.
Studies with some influenza B viruses in cell cultures, hamsters and hamster tracheal organ cultures.
Reeve P, Pibermann M, Gerendas B
Med Microbiol Immunol. 1981; 169(3):179-86.
PMID: 6166842
DOI: 10.1007/BF02123591.
Homotypic and heterotypic immunity of influenza A viruses induced by recombinants of the cold-adapted master strain A/Ann Arbor/6/60-ca.
Tannock G, Paul J
Arch Virol. 1987; 92(1-2):121-33.
PMID: 3800656
DOI: 10.1007/BF01310067.
Cold-adapted reassortants of influenza A virus: pathogenicity of A/Ann Arbor/6/60 X A/Alaska/6/77 reassortant viruses in vivo and in vitro.
Heath A, Maassab H, Odagiri T, DeBorde D, POTTER C
Arch Virol. 1986; 91(1-2):53-60.
PMID: 3753204
DOI: 10.1007/BF01316727.
Safety of and serum antibody response to cold-recombinant influenza A and inactivated trivalent influenza virus vaccines in older adults with chronic diseases.
Gorse G, Belshe R, Munn N
J Clin Microbiol. 1986; 24(3):336-42.
PMID: 3531226
PMC: 268909.
DOI: 10.1128/jcm.24.3.336-342.1986.
Infectivity and reactogenicity of reassortant cold-adapted influenza A/Korea/1/82 vaccines obtained from the USA and USSR.
Nicholson K, Tyrrell D, Oxford J, Wood J, Schild G, POTTER C
Bull World Health Organ. 1987; 65(3):295-301.
PMID: 3499246
PMC: 2491018.
Local and systemic antibody responses in high-risk adults given live-attenuated and inactivated influenza A virus vaccines.
Gorse G, Belshe R, Munn N
J Clin Microbiol. 1988; 26(5):911-8.
PMID: 3384914
PMC: 266485.
DOI: 10.1128/jcm.26.5.911-918.1988.
Four viral genes independently contribute to attenuation of live influenza A/Ann Arbor/6/60 (H2N2) cold-adapted reassortant virus vaccines.
SNYDER M, Betts R, DeBorde D, Tierney E, Clements M, Herrington D
J Virol. 1988; 62(2):488-95.
PMID: 3336068
PMC: 250559.
DOI: 10.1128/JVI.62.2.488-495.1988.
Biological characteristics of a cold-adapted influenza A virus mutation residing on a polymerase gene.
Odagiri T, Tosaka A, Ishida N, Maassab H
Arch Virol. 1986; 88(1-2):91-104.
PMID: 2420313
DOI: 10.1007/BF01310893.
Enhancement of anti-influenza A virus cytotoxicity following influenza A virus vaccination in older, chronically ill adults.
Gorse G, Belshe R
J Clin Microbiol. 1990; 28(11):2539-50.
PMID: 2123886
PMC: 268221.
DOI: 10.1128/jcm.28.11.2539-2550.1990.
Evaluation of a cold-adapted influenza B/Texas/84 reassortant virus (CRB-87) vaccine in young children.
Anderson E, Newman F, Maassab H, Belshe R
J Clin Microbiol. 1992; 30(9):2230-4.
PMID: 1400985
PMC: 265484.
DOI: 10.1128/jcm.30.9.2230-2234.1992.
